DNA
Ginkgo Bioworks Holdings
9.40$
+17.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -3.2% | +206.7% | +22.6% | -34.4% | -17.3% | -18.7% | |
| – | -16.7% | +304.0% | -15.8% | -30.9% | -39.8% | -21.7% | |
| – | -23.1% | +307.0% | -15.1% | -28.3% | -40.5% | -70.2% | |
| – | -23.1% | +307.0% | -15.1% | -28.3% | -40.5% | -24.7% | |
| – | +185.3% | +584.3% | -43.9% | -78.7% | +25.4% | +7.1% | |
| – | – | -63.7% | +29.8% | -98.9% | – | – | |
| – | +92.4% | +20.0% | +390.9% | -44.5% | +50.6% | -11.6% | |
| – | +0.0% | +1,047.7% | +182.5% | -18.2% | -100.0% | – | |
| – | -14.3% | +557.0% | +413.1% | -25.5% | -12.4% | -21.5% | |
| – | +4.9% | +145.5% | +59.5% | -29.2% | +16.4% | -7.6% | |
| – | +82.7% | +84.0% | +28.3% | -5.3% | -34.5% | -10.5% | |
| – | -18.9% | +54.0% | +3,826.6% | -40.4% | +65.8% | -21.3% | |
| – | +469.6% | -41.1% | +27.6% | -10.8% | +52.0% | -25.4% | |
| – | -6.4% | +226.3% | +15.3% | -36.8% | -34.7% | -29.0% | |
| – | – | – | – | – | – | – | |
| – | +10.9% | +6.7% | +23.5% | +15.8% | +6.8% | +6.9% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.